Buyback complete: 16 lakh shares extinguished, capital reduced

Corporate Actions View source PDF Explain this filing

JAGSNPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.2%Reaction day

₹201.50

prior close

₹201.74

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+0.0% vs market

Pharmaceuticals peers, median of 163sector-0.0%+0.3% vs sector

On the reaction day the stock moved in line with Nifty Microcap 250 and 0.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

+0.2

15m

+0.6

30m

+1.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.2+0.2+0.0-0.0+0.3

Next day

+2.2+1.1+1.1+0.2+2.0

+0.3+1.1-0.8+0.5-0.3

-2.0-0.9-1.1-0.2-1.8

+0.7+1.0-0.2+0.7+0.0

+1.7-0.5+2.2+0.1+1.7

+5.4+1.4+4.0+0.8+4.6

15d

+13.4+6.2+7.2+4.4+9.0

+18.0+7.1+10.9+6.5+11.6

+17.1+8.0+9.2+6.3+10.9

+20.8+11.2+9.6+7.9+12.9

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 163Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Jagsonpal Pharmaceuticals completed its buyback via tender offer, extinguishing 16,00,000 equity shares (about 2.38 percent of capital). Paid-up equity capital fell from 6.71 crore shares to 6.55 crore shares worth Rs 13.11 crore at Rs 2 face value. Promoter holding rose from 67.71 percent to 69.36 percent as public shareholders tendered shares.

Likely market impact

Share count drops 2.38%, lifting promoter stake to 69.36%. Marginally positive for EPS on remaining shares.